相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
Katherine M. Aird et al.
CELL CYCLE (2014)
Response to First-Line Chemotherapy in Patients with Non-Small Cell Lung Cancer According to RRM1 Expression
Xiaopeng Dong et al.
PLOS ONE (2014)
Reversible, Long-Range Radical Transfer in E-coli Class la Ribonucleotide Reductase
Ellen C. Minnihan et al.
ACCOUNTS OF CHEMICAL RESEARCH (2013)
Depletion of Deoxyribonucleotide Pools Is an Endogenous Source of DNA Damage in Cells Undergoing Oncogene-Induced Senescence
Sudha Mannava et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Uncoupling of Allosteric and Oligomeric Regulation in a Functional Hybrid Enzyme Constructed from Escherichia coli and Human Ribonucleotide Reductase
Yuan Fu et al.
BIOCHEMISTRY (2013)
Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine
Charlotte L. T. Jorgensen et al.
BMC CANCER (2013)
An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
Sarah B. Fisher et al.
CANCER (2013)
A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
Hao Tang et al.
CLINICAL CANCER RESEARCH (2013)
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers
Xiyong Liu et al.
CLINICAL SCIENCE (2013)
Ribonucleotide Reductase Association with Mammalian Liver Mitochondria
Korakod Chimploy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Replication stress links structural and numerical cancer chromosomal instability
Rebecca A. Burrell et al.
NATURE (2013)
Hypermutability and error catastrophe due to defects in ribonucleotide reductase
Deepti Ahluwalia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
Katherine M. Aird et al.
CELL REPORTS (2013)
Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion
Sudha Mannava et al.
AGING-US (2012)
Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells
Piyanuch Wonganan et al.
CANCER BIOLOGY & THERAPY (2012)
Sensitizing Cancer Cells: Is It Really All about U?
Patrick J. Stover et al.
CANCER CELL (2012)
Tumor Cells Require Thymidylate Kinase to Prevent dUTP Incorporation during DNA Repair
Chun-Mei Hu et al.
CANCER CELL (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair
Vincenzo D'Angiolella et al.
CELL (2012)
A molecular view on signal transduction by the apoptosome
Thomas F. Reubold et al.
CELLULAR SIGNALLING (2012)
Clofarabine Targets the Large Subunit (α) of Human Ribonucleotide Reductase in Live Cells by Assembly into Persistent Hexamers
Yimon Aye et al.
CHEMISTRY & BIOLOGY (2012)
DNA building blocks: keeping control of manufacture
Anders Hofer et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Mechanistic Studies of Semicarbazone Triapine Targeting Human Ribonucleotide Reductase in Vitro and in Mammalian Cells TYROSYL RADICAL QUENCHING NOT INVOLVING REACTIVE OXYGEN SPECIES
Yimon Aye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA Synthesis
Donald D. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
Mohammad Aminur Rahman et al.
JOURNAL OF CONTROLLED RELEASE (2012)
p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells
Shigeto Matsushita et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: A meta-analysis
Weiyi Gong et al.
LUNG CANCER (2012)
Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells
Giovanna Pontarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair
Ai-Guo Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Class I Ribonucleotide Reductases: Metallocofactor Assembly and Repair In Vitro and In Vivo
Joseph A. Cotruvo et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
Xiyong Liu et al.
CANCER RESEARCH (2011)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
Association of RRM1-37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy
J. Rodriguez et al.
EUROPEAN JOURNAL OF CANCER (2011)
Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): A combined experimental and theoretical study
Ana Popovic-Bijelic et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Lars Petter Jordheim et al.
LANCET ONCOLOGY (2011)
Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization
James Wesley Fairman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Clofarabine 5′-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit
Yimon Aye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Increase in dNTP pool size during the DNA damage response plays a key role in spontaneous and induced-mutagenesis in Escherichia coli
Stephanie Gon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase
Jennifer Sigmond et al.
ANTI-CANCER DRUGS (2010)
Beyond hairy cell: the activity of cladribine in other hematologic malignancies
Darren S. Sigal et al.
BLOOD (2010)
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer
Gabriella Ferrandina et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Break-induced ATR and Ddb1-Cul4Cdt2 ubiquitin ligase-dependent nucleotide synthesis promotes homologous recombination repair in fission yeast
Jennifer Moss et al.
GENES & DEVELOPMENT (2010)
Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase
Hiroyuki Niida et al.
GENES & DEVELOPMENT (2010)
Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
Teppei Morikawa et al.
HISTOPATHOLOGY (2010)
Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro
Teppei Morikawa et al.
HUMAN PATHOLOGY (2010)
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
Manuela Ferracin et al.
MOLECULAR CANCER (2010)
Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances
Chiara Rampazzo et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
A Heterozygous Truncating Mutation in RRM2B Causes Autosomal-Dominant Progressive External Ophthalmoplegia with Multiple mtDNA Deletions
Henna Tyynismaa et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
C. M. Nutting et al.
ANNALS OF ONCOLOGY (2009)
Thioredoxins and Glutaredoxins: Unifying Elements in Redox Biology
Yves Meyer et al.
ANNUAL REVIEW OF GENETICS (2009)
Mitochondrial Neurogastrointestinal Encephalopathy Due to Mutations in RRM2B
Aziz Shaibani et al.
ARCHIVES OF NEUROLOGY (2009)
Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase
Lijun Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Activity of ribonucleotide reductase helps determine how cells repair DNA double strand breaks
Martin D. Burkhalter et al.
DNA REPAIR (2009)
Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
S. Walker et al.
HEALTH TECHNOLOGY ASSESSMENT (2009)
Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response
Yong-Wei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small-Cell Lung Cancer
Craig Reynolds et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
Keqiang Zhang et al.
MOLECULAR CANCER (2009)
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems
Daniela Reischl et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion
Gittan Kollberg et al.
NEUROMUSCULAR DISORDERS (2009)
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
H. Akita et al.
ONCOGENE (2009)
Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway
Souichi Yanamoto et al.
ORAL ONCOLOGY (2009)
Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms
Xia Xu et al.
CANCER RESEARCH (2008)
Nucleic Acids as Therapeutic Agents
Luis M. Alvarez-Salas
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Identification of pathways controlling DNA damage induced mutation in Saccharomyces cerevisiae
Ewa T. Lis et al.
DNA REPAIR (2008)
Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer
Gerold Bepler et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Replication fork movement sets chromatin loop size and origin choice in mammalian cells
Sylvain Courbet et al.
NATURE (2008)
Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide
Olivier Guittet et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage
Nasim Sabouri et al.
NUCLEIC ACIDS RESEARCH (2008)
ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage
Lufen Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage
Giovanna Pontarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress
Xin Quan Ge et al.
GENES & DEVELOPMENT (2007)
Enhanced subunit interactions with gemcitabine-5′-diphosphate inhibit ribonucleotide reductases
Jun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer
George Simon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Concomitant chemoradiation versus radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: Final result of a phase III trial
A. Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
p53R2-dependent ribonucleotide reduction provides Deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage
Giovanna Pontarin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion
Alice Bourdon et al.
NATURE GENETICS (2007)
Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
Takao Itoi et al.
JOURNAL OF GASTROENTEROLOGY (2007)
RNA interference targeting the R2 subunit of ribonucleotide reductase inhibits growth of tumor cells in vitro and in vivo
Tina M. Avolio et al.
ANTI-CANCER DRUGS (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer
Zhong Zheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G(1) arrest under UV irradiation
Lijun Xue et al.
CANCER RESEARCH (2007)
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P. Ceppi et al.
ANNALS OF ONCOLOGY (2006)
Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells
Xiyong Liu et al.
CLINICAL CANCER RESEARCH (2006)
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer
Gerold Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Discovery and development of clofarabine: a nucleoside analogue for treating cancer
Peter L. Bonate et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Enzymatically active mammalian ribonucleotide reductase exists primarily as an α6β2 octamer
Reza Rofougaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
N-Hydroxyurea -: A versatile zinc binding function in the design of metalloenzyme inhibitors
Claudia Temperini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Ribonucleotide reductase inhibitors and future drug design
J. Shao et al.
CURRENT CANCER DRUG TARGETS (2006)
DNA precursor metabolism and genomic stability
Christopher K. Mathews
FASEB JOURNAL (2006)
Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase
Ashish Gautam et al.
CANCER RESEARCH (2006)
Intracellular nucleotides act as critical prosurvival factors by binding to cyctochrome c and inhibiting apoptosome
Dhyan Chandra et al.
CELL (2006)
Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma
H Okumura et al.
CLINICAL CANCER RESEARCH (2006)
Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells
P Håkansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Stimulation of mutagenesis by proportional deoxyribonucleoside triphosphate accumulation in Escherichia coli
LJ Wheeler et al.
DNA REPAIR (2005)
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant
AM Bergman et al.
CANCER RESEARCH (2005)
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells
LP Jordheim et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells
S Yanamoto et al.
CANCER LETTERS (2005)
Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer
J Pfisterer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias
S Faderl et al.
BLOOD (2005)
S phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region
AL Chabes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
被撤回的出版物: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia
S Lindemalm et al.
CANCER LETTERS (2004)
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer
MS Duxbury et al.
SURGERY (2004)
Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors
ZP Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
JD Davidson et al.
CANCER RESEARCH (2004)
RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer
G Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Dynamics of DNA replication in mammalian somatic cells: Nucleotide pool modulates origin choice and interorigin spacing
M Anglana et al.
CELL (2003)
Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools
T Kimura et al.
NATURE GENETICS (2003)
Gene expression profiles of human breast cancer progression
XJ Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
RRM1-induced metastasis suppression through PTEN-regulated pathways
A Gautam et al.
ONCOGENE (2003)
Mouse ribonucleotide reductase R2 protein: A new target for anaphase-promoting complex-Cdh1-mediated proteolysis
AL Chabes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma
S Yanamoto et al.
CANCER LETTERS (2003)
Comprehensive model for allosteric regulation of mammalian ribonucleotide reductase: Refinements and consequences
OB Kashlan et al.
BIOCHEMISTRY (2003)
Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase
A Chabes et al.
CELL (2003)
Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance
E Månsson et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity
KR Martin et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells
O Guittet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy
A Saada et al.
NATURE GENETICS (2001)
The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA
H Mandel et al.
NATURE GENETICS (2001)
The DNA damage response: putting checkpoints in perspective
BBS Zhou et al.
NATURE (2000)
A ribonucleotide reductase gene is a transcriptional target of p53 and p73
K Nakano et al.
ONCOGENE (2000)
Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks
A Chabes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Triapine (3-aminopyridine-2-carboxaldehydethiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity
RA Finch et al.
BIOCHEMICAL PHARMACOLOGY (2000)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
H Tanaka et al.
NATURE (2000)
Gemcitabine in non-small cell lung cancer (NSCLC)
C Manegold et al.
INVESTIGATIONAL NEW DRUGS (2000)
分享论文
